期刊文献+

结外型口腔恶性淋巴瘤临床病理分析 被引量:5

Clinicopathology of Extra-nodal Lymphoma in Oral and Maxillofacial Region
下载PDF
导出
摘要 目的:研究结外型口腔恶性淋巴瘤的发病情况和临床病理特点。方法:对青岛大学医学院附属医院口腔颌面外科1988-07—2008-12收治的24例结外型口腔恶性淋巴瘤患者进行回顾性临床病理分析,研究其发病年龄、发病部位、病理分型及临床表现。结果:结外型口腔恶性淋巴瘤发病率低,分布于各个年龄段,男性发病多于女性,可发生于舌根、腭、颊、唇、牙龈等部位,临床表现多样,多为非霍奇金淋巴瘤,以B细胞恶性淋巴瘤多见。结论:结外型口腔恶性淋巴瘤临床表现多样,应注意鉴别诊断。肿块切取活检,辅以全身系统性检查,是诊断结外型口腔恶性淋巴瘤的有效手段。 Objective: To study the prevalence situation, clinicopathologic features of extra-nodal lymphoma in oral and maxillofacial region. Methods: The elinicopathologic features of 24 cases from July 1988 to December 2008 were investigated, including onset ages, site, classification and clinical manifestations. Results: The incidence rate of extra- nodal lymphoma in oral and maxillofacial region was lower. It occurred in every age group, with males more than females. It located in tongue base, palate, bucea, lip, gum. Clinical manifestations of oral lymphoma were varied, including tumor, inflammation, ulcer and necrosis. The pathological diagnosis were mainly non-Hodgkin' s lymphoma, most of them were B cell malignant lymphoma. Conclusion: Clinical manifestations of extra-nodal lymphoma in oral and maxillofaeial regions were diversed. Differential diagnosis should be careful. Mass biopsy and general physical examination would be ,helpful to the diagnosis.
出处 《口腔颌面外科杂志》 CAS 2010年第3期183-186,共4页 Journal of Oral and Maxillofacial Surgery
关键词 颌面部肿瘤 淋巴瘤 病理学 oral and maxillofacial tumor lymphoma pathology
  • 相关文献

参考文献11

二级参考文献64

  • 1杨侃,刘艳辉.苏州,南京,青岛与沈阳四地区恶性淋巴瘤的病理组织学与免疫学...[J].中华肿瘤杂志,1993,15(2):86-90. 被引量:17
  • 2邱蔚六 林国础 等.口腔颌面部非何杰金氏淋巴瘤[J].中华口腔医学杂志,1998,20(2):78-80.
  • 3吴宝龙 李永学 李桃贤 等.罕见的恶性淋巴瘤[J].中华肿瘤杂志,1985,7(3):211-211.
  • 4王佩玉 高云峰 童维新 等.恶性淋巴瘤误诊原因分析一附45例报告.中华肿瘤杂志,1987,9(6):439-439.
  • 5Asaumi J, YanagiY, HisatomiM, et al. The value of dynamic contrast-enhancedMRI in diagnosisofmalignant lymphoma of the head and neck[J].Eur J Radio, 2003, 48(2): 183-184.
  • 6[1]Harris N,Jaffe E,Stein H,et al.A revised European-Amreican classification of lymphoid neoplasms:A proposal from the International Lymphoma Study Group.Blood,1994,84:1361
  • 7[2]Jaffe E,Harris N,Diebold J,et al.World health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues:A progress report.Am J Clin Pathol,1999,111(Suppl 1):S8
  • 8[3]Ghielmini M,Schmitz S,Cogliatti S,et al.Prolonged treatment with 2-monthly rituximab significantly improves eventfree survival and duration of response in patients with follicular lymphoma:A randomized SAKK Trial.Blood,2002 (Abstr),100:161A
  • 9[4]Witzig T,Vukov A,Habermann T,et al.Rituximab therapy for patients with newly diagnosed,asymptomatic advancedstage follicular gradel non-Hodgkin's lymphoma (NHL):A phase Ⅱ trial in the the North Central Cancer Treatment Group(NCCTG).Blood,2002 (Abstr),100:361A
  • 10[5]Solal-Celigny P,Salles GA,Brousse N et al.Single 4-dose rituximab treatment for low tumor burden lymphoma (FL):Survival analyses with a follow-up (F/Up) of at least 5 years.Blood,2004,104 (Abstr):585

共引文献23

同被引文献52

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部